International Journal of Dermatology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 10, 2025
ABSTRACT
The
concept
of
aging
has
evolved
from
being
primarily
attributed
to
genetic
factors
recognizing
the
critical
role
epigenetic
mechanisms.
Recent
advancements,
such
as
clocks,
have
provided
tools
assess
biological
age
and
offer
insights
into
processes
at
molecular
level.
In
aesthetic
dermatology,
understanding
these
allows
for
more
personalized,
effective
interventions
targeting
root
causes
skin
aging.
This
review
explores
interplay
changes,
aging,
potential
personalized
care
enhance
longevity
rejuvenation.
is
based
on
an
extensive
literature
search
conducted
across
PubMed
other
scientific
databases.
Studies
focused
mechanisms
DNA
methylation,
histone
modifications,
their
relationship
Particular
attention
was
given
recent
advancements
in
including
Horvath's
Clock
GrimAge,
implications
dermatological
treatments.
Epigenetic
Clock,
demonstrated
utility
assessing
through
methylation
markers,
revealing
actionable
processes.
Energy‐based
devices
like
fractional
lasers
radiofrequency
shown
promise
reversing
age‐related
promoting
collagen
synthesis,
reducing
age.
Additionally,
lifestyle
diet,
sleep,
circadian
rhythm
alignment
significantly
influence
health.
Integrating
dermatology
represents
a
paradigm
shift
rejuvenation,
allowing
treatments
that
address
visible
signs
underlying
Using
clocks
provides
framework
tailoring
individual
patient
needs,
optimizing
outcomes,
extending
results.
Future
research
should
focus
longitudinal
studies,
accessibility,
ethical
considerations
fully
harness
epigenetics
health
overall
well‐being.
The
advent
of
iPSCs
has
brought
about
a
significant
transformation
in
stem
cell
research,
opening
up
promising
avenues
for
advancing
cancer
treatment.
formation
is
multifaceted
process
influenced
by
genetic,
epigenetic,
and
environmental
factors.
offer
distinctive
platform
investigating
the
origin
cancer,
paving
way
novel
approaches
to
treatment,
drug
testing,
tailored
medical
interventions.
This
review
article
will
provide
an
overview
science
behind
iPSCs,
current
limitations
challenges
iPSC-based
therapy,
ethical
social
implications,
comparative
analysis
with
other
types
also
discuss
applications
tumorigenesis,
future
tumorigenesis
highlight
successful
case
studies
utilizing
research.
conclusion
summarize
advancements
made
research
importance
continued
investment
iPSC
unlock
full
potential
these
cells.
Advanced Materials,
Год журнала:
2024,
Номер
36(34)
Опубликована: Июнь 11, 2024
The
repair
and
functional
reconstruction
of
bone
defects
resulting
from
severe
trauma,
surgical
resection,
degenerative
disease,
congenital
malformation
pose
significant
clinical
challenges.
Bone
tissue
engineering
(BTE)
holds
immense
potential
in
treating
these
defects,
without
incurring
prevalent
complications
associated
with
conventional
autologous
or
allogeneic
grafts.
3D
printing
technology
enables
control
over
architectural
structures
at
multiple
length
scales
has
been
extensively
employed
to
process
biomimetic
scaffolds
for
BTE.
In
contrast
inert
grafts,
next-generation
smart
possess
a
remarkable
ability
mimic
the
dynamic
nature
native
extracellular
matrix
(ECM),
thereby
facilitating
regeneration.
Additionally,
they
can
generate
tailored
controllable
therapeutic
effects,
such
as
antibacterial
antitumor
properties,
response
exogenous
and/or
endogenous
stimuli.
This
review
provides
comprehensive
assessment
progress
3D-printed
BTE
applications.
It
begins
an
introduction
physiology,
followed
by
overview
technologies
utilized
scaffolds.
Notable
advances
various
stimuli-responsive
strategies,
efficacy,
applications
are
discussed.
Finally,
highlights
existing
challenges
development
implementation
scaffolds,
well
emerging
this
field.
Ageing Research Reviews,
Год журнала:
2024,
Номер
95, С. 102204 - 102204
Опубликована: Янв. 23, 2024
The
pursuit
for
the
fountain
of
youth
has
long
been
a
fascination
amongst
scientists
and
humanity.
Ageing
is
broadly
characterized
by
cellular
decline
with
increased
susceptibility
to
age-related
diseases,
being
intimately
associated
epigenetic
modifications.
Recently,
reprogramming-induced
rejuvenation
strategies
have
begun
greatly
alter
longevity
research
not
only
tackle
defects
but
also
possibly
reverse
ageing
process.
Hence,
in
this
review,
we
highlight
major
changes
during
state-of-art
current
emerging
reprogramming
leveraging
on
transcription
factors.
Notably,
partial
enables
resetting
clock
without
erasing
identity.
Promising
chemical-based
harnessing
small
molecules,
including
DNA
methyltransferase
histone
deacetylase
inhibitors
are
discussed.
Moreover,
parallel
interventions,
foundations
clocks
accurate
assessment
evaluation
approaches
briefly
presented.
Going
further,
such
scientific
breakthroughs,
witnessing
rise
biotech
industry
aiming
extend
health
span
ideally
achieve
human
one
day.
In
context,
overview
main
scenarios
proposed
future
socio-economic
ethical
challenges
an
field.
Ultimately,
review
aims
inspire
interventions
that
promote
healthy
all.
Non-coding RNA Research,
Год журнала:
2024,
Номер
9(2), С. 277 - 287
Опубликована: Янв. 26, 2024
The
intricate
molecular
landscape
of
cancer
pathogenesis
continues
to
captivate
researchers
worldwide,
with
Circular
RNAs
(circRNAs)
emerging
as
pivotal
players
in
the
dynamic
regulation
biological
functions.
study
investigates
elusive
link
between
circRNAs
and
Transforming
Growth
Factor-β
(TGF-β)
signalling
pathway,
exploring
their
collective
influence
on
progression
metastasis.
Our
comprehensive
investigation
begins
by
profiling
circRNA
expression
patterns
diverse
types,
revealing
a
repertoire
intricately
linked
TGF-β
pathway.
Through
integrated
bioinformatics
analyses
functional
experiments,
we
elucidate
specific
circRNA-mRNA
interactions
that
modulate
signalling,
unveiling
regulatory
controls
governing
this
crucial
Furthermore,
provide
compelling
evidence
impact
circRNA-mediated
modulation
key
cellular
processes,
including
epithelial-mesenchymal
transition
(EMT),
migration,
cell
proliferation.
In
addition
mechanistic
roles,
have
shown
promise
diagnostic
prognostic
biomarkers,
well
potential
targets
for
therapy.
Their
ability
critical
pathways,
such
axis,
underscores
significance
biology
clinical
applications.
interplay
is
dissected,
uncovering
novel
circuits
contribute
complexity
biology.
This
review
unravels
previously
unexplored
dimension
carcinogenesis,
emphasizing
role
shaping
landscape.
Since
their
first
production
in
2007,
human
induced
pluripotent
stem
cells
(iPSCs)
have
provided
a
novel
platform
for
the
development
of
various
cell
therapies
targeting
spectrum
diseases,
ranging
from
rare
genetic
eye
disorders
to
cancer
treatment.
However,
several
challenges
must
be
tackled
iPSC-based
therapy
enter
market
and
achieve
broader
global
adoption.
This
white
paper,
authored
by
Japanese
Society
Regenerative
Medicine
(JSRM)
-
International
Cell
Therapy
(ISCT)
iPSC
Committee
delves
into
hurdles
encountered
pursuit
safe
economically
viable
therapies,
particularly
standpoint
industry.
It
discusses
differences
guidelines
regulatory
frameworks,
outlines
series
quality
control
tests
required
ensure
safety
therapy,
provides
details
important
considerations
around
cost
goods
(COGs),
including
impact
automated
advanced
manufacturing.
Abstract
Aging
exhibits
several
hallmarks
in
common
with
cancer,
such
as
cellular
senescence,
dysbiosis,
inflammation,
genomic
instability,
and
epigenetic
changes.
In
recent
decades,
research
into
the
role
of
senescence
on
tumor
progression
has
received
widespread
attention.
While
how
limits
course
cancer
is
well
established,
also
been
found
to
promote
certain
malignant
phenotypes.
The
tumor‐promoting
effect
mainly
elicited
by
a
senescence‐associated
secretory
phenotype,
which
facilitates
interaction
senescent
cells
their
surroundings.
Targeting
therefore
offers
promising
technique
for
therapy.
Drugs
that
pharmacologically
restore
normal
function
or
eliminate
them
would
assist
reestablishing
homeostasis
cell
signaling.
Here,
we
describe
its
occurrence,
impact
biology.
A
“one‐two‐punch”
therapeutic
strategy
first
induced,
followed
use
senotherapeutics
eliminating
introduced.
advances
application
targeting
treatment
are
outlined,
an
emphasis
drug
categories,
strategies
screening,
design,
efficient
targeting.
This
work
will
foster
thorough
comprehension
encourage
additional
within
this
field.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Май 29, 2024
Despite
substantial
evidence
emphasizing
the
pleiotropic
benefits
of
exercise
for
prevention
and
treatment
various
diseases,
underlying
biological
mechanisms
have
not
been
fully
elucidated.
Several
attributed
to
signaling
molecules
that
are
released
in
response
by
different
tissues
such
as
skeletal
muscle,
cardiac
adipose,
liver
tissue.
These
molecules,
which
collectively
termed
exerkines,
form
a
heterogenous
group
bioactive
substances,
mediating
inter-organ
crosstalk
well
structural
functional
tissue
adaption.
Numerous
scientific
endeavors
focused
on
identifying
characterizing
new
mediators
with
properties.
Additionally,
some
investigations
molecular
targets
exerkines
cellular
cascades
trigger
adaption
processes.
A
detailed
understanding
tissue-specific
downstream
effects
is
crucial
harness
health-related
mediated
improve
targeted
programs
health
disease.
Herein,
we
review
current
vivo
exerkine-induced
signal
transduction
across
multiple
target
highlight
preventive
therapeutic
value
exerkine
diseases.
By
aspects
research,
provide
comprehensive
overview
(i)
underpinnings
secretion,
(ii)
receptor-dependent
receptor-independent
adaption,
(iii)
clinical
implications
these
disease
treatment.
Pharmaceuticals,
Год журнала:
2024,
Номер
17(3), С. 312 - 312
Опубликована: Фев. 28, 2024
Aging
is
a
known
co-morbidity
of
ischemic
stroke
with
its
risk
and
severity
increasing
every
year
past
55+.
While
many
the
current
therapies
have
shown
success
in
reducing
mortality,
post-stroke
morbidity
has
not
seen
same
substantial
reduction.
Recently,
involvement
cellular
senescence
SASP
brain
injury
neurological
degeneration
been
recognized.
Ischemic
causes
oxidative
stress
mitochondrial
damage
that
induces
through
activation
p21
p16
pathways,
ultimately
leading
to
synthesis
release
senescence-associated
secretory
phenotype
(SASP).
This
event
stress-induced
premature
(SIPS),
aging
decades
beyond
standard
biological
age
due
an
increase
senescent
cells
core
ipsilateral
hemisphere.
Therefore,
target
SASP,
including
senolytics,
senomorphic
drugs,
stem
cell
therapies,
other
cell-specific
interventions,
may
be
new
path
for
treatment.
Biomedicines,
Год журнала:
2025,
Номер
13(1), С. 86 - 86
Опубликована: Янв. 1, 2025
Urothelial
carcinoma
(UC)
is
the
most
common
histological
subtype
of
bladder
tumors;
however,
cancer
represents
a
heterogeneous
group
diseases
with
at
least
40
distinct
subtypes.
Among
these,
2022
World
Health
Organization
classification
urinary
tract
tumors
identifies
range
less
subtypes
invasive
UC,
formerly
known
as
variants,
which
are
considered
high-grade
tumors,
including
squamous
cell,
small-cell,
sarcomatoid
urothelial,
micropapillary,
plasmacytoid,
and
urachal
carcinomas,
adenocarcinoma.
Their
accurate
diagnosis
critical
for
risk
stratification
therapeutic
decision-making,
histologies
associated
poorer
outcomes
than
conventional
UC.
Despite
importance
precise
diagnosis,
high-quality
evidence
on
optimal
treatments
remains
limited
owing
to
their
rarity.
In
particular,
neoadjuvant
adjuvant
chemotherapy
have
not
been
well
characterized,
prospective
data
scarce.
For
advanced-stage
diseases,
clinical
trial
participation
strongly
recommended
address
lack
robust
evidence.
Advances
in
molecular
pathology
development
targeted
therapies
immunotherapies
reshaped
our
understanding
subtypes,
spurring
efforts
identify
predictive
biomarkers
guide
personalized
treatment
strategies.
Nevertheless,
management
rare
subgroups
challenging
because
they
frequently
excluded
from
trials.
localized
disease,
curative
options
such
surgical
resection
or
radiotherapy
available;
become
more
recurrence
metastasis,
where
systemic
therapy
primarily
used
control
disease
progression
palliate
symptoms.
Herein,
we
present
recent
advances
urothelial
non-urothelial
also
explore
current
guiding
emphasize
challenges
perspectives
future